The ongoing dedicated ophthalmic trial named as FOCUS study, which aims to evaluate semaglutides long-term effects on diabetic retinopathy, is now ongoing and could contribute to a comprehensive understanding of the true risk-benefit profile of these agents in patients with or at risk for diabetic retinopathy (NCT03811561) [104]
What this means for Washington State Medicare beneficiaries in 2026: For a full overview of how Medicare Parts A, B, C, and D work together in Washington, see our guide: Medicare Parts A, B, C & D in Washington State Explained
Combining this treatment with a balanced diet rich in essential nutrients and engaging in light, regular physical activity can greatly enhance your recovery
It has been studied for roles in actin binding, cell movement, angiogenesis, inflammation modulation, and wound healing
Rutgeerts P, Lfberg R, et al
Why are Cagrilintide combinations listed in this category